Showing results (1-10 of 797) with videos related to
Sort By:
Pageof 80
Blood|August 1, 2020
What is the future of immunotherapy in multiple myeloma?Leo Rasche, Michael Hudecek, Hermann EinseleBlood|November 30, 2023
CAR T-cell therapy in multiple myeloma: mission accomplished?Leo Rasche, Michael Hudecek, Hermann EinseleJournal of Visualized Experiments : Jove|October 21, 2024
Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon SystemMaximilian Bauser, Hermann Einsele, Jürgen Löffler, et al.Advances in Cell and Gene Therapy|November 14, 2018
CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical modelsLars Wallstabe, Andreas Mades, Silke Frenz, et al.Cancers|December 24, 2021
Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid LeukemiaMarius Maucher, Micha Srour, Sophia Danhof, et al.Frontiers in Immunology|January 11, 2021
Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management StrategiesXiang Zhou, Leo Rasche, K Martin Kortüm, et al.Nature Reviews. Clinical Oncology|September 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunitiesKarl Petri, Elvira D'Ippolito, Annette Künkele, et al.Leukemia & Lymphoma|November 24, 2023
BCMA CAR-T cells in multiple myeloma-ready for take-off?Lukas Scheller, Erius Tebuka, Peter Fabian Rambau, et al.Nature Communications|July 19, 2019
Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-TThomas Nerreter, Sebastian Letschert, Ralph Götz, et al.Frontiers in Oncology|August 28, 2020
CAR T-Cells in Multiple Myeloma: State of the Art and Future DirectionsLuis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, et al.Pageof 80